SCHEMBL7418832

SCHEMBL7418832

CC(=O)N1CCc2cc3[nH]cc(C)c3cc21

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
HPGD P15428 1/20 0.55
NOTUM Q6P988 8/20 0.51
CDK4 P11802 3/20 0.44
CCND1 P24385 3/20 0.44
CYP11B2 P19099 4/20 0.43
CYP11B1 P15538 2/20 0.43
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PKM P14618 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6992985 0.79 HTR1D (0.55) KDM4EALDH1A1MAPT
SCHEMBL6997808 0.76 SLC6A4 (0.55) KDM4E
SCHEMBL6213822 0.73 NOTUM (0.52) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL7422396 0.72 ALDH1A1 (0.55) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL21469189 0.72 NOTUM (0.58) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL29803331 0.71 NOTUM (0.60) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL22462287 0.71 NOTUM (0.60) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL9832984 0.70 KDM4E (0.50) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL9832596 0.69 KDM4E (0.52) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL13059953 0.69 NOTUM (0.57) KDM4EALDH1A1HPGDNOTUMCYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0656003-A1 CONDENSED INDOLE DERIVATIVES AS 5HT2C AND 5HT2B ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-06-07 EP disclosed
WO-1994004533-A1 CONDENSED INDOLE DERIVATIVES AS 5HT2C AND 5HT2B ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-03-03 WO disclosed